Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7759/cureus.16149 http://scihub22266oqcxt.onion/10.7759/cureus.16149 34262828!8260201!34262828     free     free     free       Cureus 2021 ; 13 (7): e16149 Nephropedia Template TP {{tp|p=34262828|t=2021. Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient |pdf=|usr=}}{{34262828}} gab.com Text Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient JO: Cureus http://www.kidney.de/pget.php?&tw=1&pmid=34262828 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described in patients in Wuhan, China, who presented with flu-like symptoms. Since then, it has spread all over the world and in March 2020 it was labeled as a pandemic by the World Health Organization. Most common presentations include respiratory symptoms that vary from mild cough and shortness of breath to severe acute respiratory distress syndrome. Gastrointestinal symptoms like nausea, vomiting and diarrhea are also common. However, cardiovascular complications have not been reported widely. Patients can present with cardiac complications that include chest pain, heart failure and fulminant myocarditis, which is one of the most serious cardiac manifestations. Primary means of diagnosis are echocardiogram and cardiac magnetic imaging. Treatment is mostly supportive in case of cardiogenic shock and includes ionotropic support with or without mechanical circulatory support and mechanical ventilation. A strong suspicion is required for early diagnosis and aggressive treatment in order to reduce mortality and morbidity. Twit Text FOAVip Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient ????Cureus http://www.kidney.de/pget.php?&tw=1&pmid=34262828 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34262828 #FOAvip English Wikipedia <ref>{{Cite pmid|34262828}}</ref> Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient #MMPMID34262828 Ghafoor K; Ahmed A; Abbas M Cureus 2021[Jul]; 13 (7): e16149 PMID34262828show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described in patients in Wuhan, China, who presented with flu-like symptoms. Since then, it has spread all over the world and in March 2020 it was labeled as a pandemic by the World Health Organization. Most common presentations include respiratory symptoms that vary from mild cough and shortness of breath to severe acute respiratory distress syndrome. Gastrointestinal symptoms like nausea, vomiting and diarrhea are also common. However, cardiovascular complications have not been reported widely. Patients can present with cardiac complications that include chest pain, heart failure and fulminant myocarditis, which is one of the most serious cardiac manifestations. Primary means of diagnosis are echocardiogram and cardiac magnetic imaging. Treatment is mostly supportive in case of cardiogenic shock and includes ionotropic support with or without mechanical circulatory support and mechanical ventilation. A strong suspicion is required for early diagnosis and aggressive treatment in order to reduce mortality and morbidity. ?Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SAR(epmc).pdf DeepDyve Pubget Overpricing